No Picture
News

Qualigen obtains exclusive license to novel cancer drug technology from Advanced Cancer Therapeutics

Qualigen continues to strengthen its cancer drug technology portfolio

CARLSBAD, Calif., Dec. 18, 2018 /PRNewswire/ — Qualigen, Inc., and Advanced Cancer Therapeutics, LLC (ACT) today announced that Qualigen has licensed certain ACT patents, intellec… […]

No Picture
News

Ajinomoto and XL-protein Forge Strategic Alliance to Develop PASylated Therapeutics Applying the Corynex® Platform

SAN DIEGO and FREISING, Germany, Dec. 18, 2018 /PRNewswire/ — Ajinomoto Bio-Pharma Services, a fully owned subsidiary of Ajinomoto Co. Inc. (TSE: 2802), and XL-protein GmbH, a privately owned German biopharmaceutical company, are pleased to announ… […]

No Picture
News

Erasca Launches with $42 Million Series A Financing to Support Bold Mission of Erasing Cancer

Company, co-founded by physician-turned-venturepreneur Dr. Jonathan E. Lim, is targeting undisclosed biological drivers of cancer

SAN DIEGO, Dec. 18, 2018 /PRNewswire/ — Erasca, a company dedicated to advancing exceptional scientific approaches to … […]

No Picture
News

Evofem Biosciences Announces Positive Top-Line Results of Phase 3 Study Evaluating Amphora for Hormone-Free Birth Control

– Top-Line Phase 3 Data Demonstrate 86.0% Efficacy, which Met Primary Study Endpoint, and 98.7% Efficacy when Used as Directed — Q2 2019 New Drug Application (NDA) Resubmission Planned — Management to Host Conference Call at 8:30 a.m. EST –

SAN DIE… […]